4//SEC Filing
HAHN ELLIOT F 4
Accession 0001192482-10-000346
CIK 0001301081other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 10:28 AM ET
Size
18.2 KB
Accession
0001192482-10-000346
Insider Transaction Report
Form 4
Pharmasset IncVRUS
HAHN ELLIOT F
Director
Transactions
- Exercise/Conversion
Common Stock
2010-12-20$20.20/sh+8,125$164,125→ 92,124 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−10,000→ 0 totalExercise: $13.67Exp: 2014-08-10→ Common Stock (10,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−15,000→ 5,000 totalExercise: $18.60Exp: 2016-05-24→ Common Stock (15,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−10,000→ 10,000 totalExercise: $21.65Exp: 2016-11-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2010-12-20$13.67/sh+10,000$136,700→ 83,999 total - Exercise/Conversion
Common Stock
2010-12-20$18.60/sh+15,000$279,000→ 107,124 total - Exercise/Conversion
Common Stock
2010-12-20$21.65/sh+10,000$216,500→ 117,124 total - Exercise/Conversion
Stock Option (Right to Buy)
2010-12-20−8,125→ 1,875 totalExercise: $20.20Exp: 2016-05-24→ Common Stock (8,125 underlying)
Footnotes (4)
- [F1]This option, which was granted on October 10, 2007, became vested over a three-year period and was fully exercisable on October 10, 2010.
- [F2]This option was granted on July 16, 2008 with a three-year vesting period and will become fully exercisable on July 16, 2011.
- [F3]This option granted on October 29, 2008 with a three-year vesting period and will become fully exercisable on October 29, 2011.
- [F4]This option was granted on October 14, 2009 with a three-year vesting period and will become fully exercisable on October 14, 2012.
Documents
Issuer
Pharmasset Inc
CIK 0001301081
Entity typeother
Related Parties
1- filerCIK 0001032729
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 10:28 AM ET
- Size
- 18.2 KB